ストックスクリーナーアプリを入手
1.75
4.37%
-0.08
前日終値:
$1.83
開ける：
$1.82
24時間の取引高:
7.66M
Relative Volume:
0.59
時価総額：
$584.38M
収益：
$32.77M
当期純損益:
$-440.22M
株価収益率:
-1.0479
EPS:
-1.67
ネットキャッシュフロー:
$-400.48M
1週間 パフォーマンス:
-1.69%
1か月 パフォーマンス:
-50.84%
6か月 パフォーマンス:
-81.22%
1年 パフォーマンス:
-80.56%
1日の値動き範囲:
$1.71
$1.828
1週間の範囲:
$1.70
$1.87
52週間の値動き範囲:
$1.6385
$12.51
Iovance Biotherapeutics Inc Stock (IOVA) Company Profile
名前
Iovance Biotherapeutics Inc
セクター
電話
(650) 260-7120
住所
825 INDUSTRIAL ROAD, SAN CARLOS
IOVA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IOVA
Iovance Biotherapeutics Inc
|
1.75 | 594.40M | 32.77M | -440.22M | -400.48M | -1.67 |
|
ONC
Beone Medicines Ltd Adr
|
245.58 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.96B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 42.96M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.39B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 63.52B | 14.09B | 4.50B | 2.96B | 39.28 |
Iovance Biotherapeutics Inc Stock (IOVA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-16 | ダウングレード | UBS | Buy → Neutral |
| 2025-05-12 | ダウングレード | Truist | Buy → Hold |
| 2025-05-09 | ダウングレード | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-10-24 | 開始されました | UBS | Buy |
| 2024-07-29 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2023-11-20 | 開始されました | Goldman | Buy |
| 2023-09-18 | 繰り返されました | Barclays | Overweight |
| 2023-05-30 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-03-27 | 再開されました | Wells Fargo | Equal Weight |
| 2023-01-27 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2022-12-09 | ダウングレード | Goldman | Buy → Neutral |
| 2022-10-31 | 開始されました | Guggenheim | Neutral |
| 2022-08-18 | 再開されました | Wells Fargo | Equal Weight |
| 2022-01-28 | アップグレード | Stifel | Hold → Buy |
| 2021-12-07 | 再開されました | Cowen | Outperform |
| 2021-06-10 | アップグレード | JMP Securities | Mkt Perform → Mkt Outperform |
| 2021-05-20 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2021-05-19 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2021-05-19 | ダウングレード | Stifel | Buy → Hold |
| 2021-05-03 | 開始されました | Truist | Buy |
| 2021-04-16 | 開始されました | Goldman | Buy |
| 2021-03-08 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2020-12-15 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2020-10-06 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-04-22 | 開始されました | Mizuho | Buy |
| 2020-03-04 | 開始されました | Barclays | Overweight |
| 2020-02-26 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-02-26 | 繰り返されました | Oppenheimer | Outperform |
| 2019-12-18 | 開始されました | JMP Securities | Mkt Outperform |
| 2019-10-01 | 開始されました | Stifel | Buy |
| 2019-04-29 | 開始されました | Piper Jaffray | Overweight |
| 2019-02-28 | 繰り返されました | Chardan Capital Markets | Buy |
| 2019-02-07 | 開始されました | Robert W. Baird | Outperform |
| 2018-12-31 | 再開されました | B. Riley FBR | Buy |
| 2018-07-06 | 繰り返されました | Chardan Capital Markets | Buy |
| 2018-04-10 | アップグレード | B. Riley FBR, Inc. | Neutral → Buy |
| 2018-03-13 | 繰り返されました | B. Riley FBR, Inc. | Neutral |
| 2018-02-23 | ダウングレード | B. Riley FBR, Inc. | Buy → Neutral |
| 2018-01-25 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-11-01 | 繰り返されました | B. Riley FBR, Inc. | Buy |
すべてを表示
Iovance Biotherapeutics Inc (IOVA) 最新ニュース
Lost Money on Iovance Biotherapeutics, Inc. (IOVA)? Contact Levi & Korsinsky to Join Class Action Before July 14, 2025 - ACCESS Newswire
IOVA LAWSUIT ALERT: Levi & Korsinsky Notifies Iovance Biotherapeutics, Inc. InvestorsLead Plaintiff Deadline July 14, 2025 - ACCESS Newswire
IOVA CLASS NOTICE: Iovance Biotherapeutics, Inc. Investors may have been Affected by Fraud – Contact BFA Law before July 14 Court Deadline (NASDAQ:IOVA) - TradingView
Lost Money on Iovance Biotherapeutics, Inc. (IOVA)? Urged to Join Class Action Before July 14, 2025Contact Levi & Korsinsky - ACCESS Newswire
IOVA Investors Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud Lawsuit - Eastern Progress
IOVA DEADLINE REMINDER: Iovance Biotherapeutics, Inc. Investors May Be Able to Recover LossesContact BFA Law by July 14 Class Action Deadline - ACCESS Newswire
Robbins LLP Reminds IOVA Stockholders That a Class Action Lawsuit was Filed Against Iovance ... - Eagle-Tribune
Robbins LLP Reminds IOVA Stockholders That a Class Action - GlobeNewswire
Robbins LLP Reminds IOVA Stockholders That a Class Action Lawsuit was Filed Against Iovance Biotherapeutics, Inc. Alleging the Company Misled Investors Regarding its Business Prospects - TradingView
Deadline Alert: Iovance Biotherapeutics, Inc. (IOVA) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - GlobeNewswire
IOVA Investors Have the Opportunity to Lead the Iovance Biotherapeutics Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - marketscreener.com
Class Action Filed Against Iovance Biotherapeutics, Inc. (IOVA)July 14, 2025 Deadline to JoinContact Levi & Korsinsky - PR Newswire
Where are the Opportunities in (IOVA) - news.stocktradersdaily.com
IOVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Investors in Iovance Biotherapeutics, Inc. Should Contact - GlobeNewswire
Investors in Iovance Biotherapeutics, Inc. Should Contact The Gross Law Firm Before July 14, 2025 to Discuss Your Rights – IOVA - TradingView
Scott+Scott Attorneys at Law LLP Continues to Remind - GlobeNewswire
Scott+Scott Attorneys at Law LLP Continues to Remind Investors an Action Has Been Filed Against Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) - TradingView
Iovance Biotherapeutics, Inc. (IOVA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Iovance Biotherapeutics, Inc. (IOVA) Investors of July 14, 2025 Deadline - ACCESS Newswire
Iovance’s (IOVA) Promising Cell Therapy Falters Triggering UBS Downgrades and Investor Lawsuit– Hagens Berman - GlobeNewswire
Iovance’s (IOVA) Promising Cell Therapy Falters Triggering UBS Downgrades and Investor Lawsuit– Hagens Berman - GlobeNewswire Inc.
IOVA REMINDER: BFA Law Reminds Iovance Biotherapeutics, Inc. Investors of the Imminent July 14 Deadline in Securities Fraud Class Action (NASDAQ:IOVA) - TradingView
IOVA LAWSUIT ALERT: The Gross Law Firm Notifies Iovance Biotherapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - marketscreener.com
IOVANCE BIOTHERAPEUTICS SHAREHOLDER ALERT: CLAIMSFILER - GlobeNewswire
Securities Class Action Lawsuit Filed Against Iovance Biotherapeutics, Inc. (IOVA)Levi & Korsinsky Represents Shareholders - ACCESS Newswire
Lawsuit filed for Investors who lost money with shares of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) - openPR.com
IOVA Investors Have the Opportunity to Lead the Iovance Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - GlobeNewswire
IOVA Investors Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Morningstar
ROSEN, LEADING INVESTOR COUNSEL, Encourages Iovance Biotherapeutics, Inc. Investors to Secure ... - Eagle-Tribune
ROSEN, LEADING INVESTOR COUNSEL, Encourages Iovance Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IOVA - TradingView
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Iovance Biotherapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesIOVA - FinancialContent
Levi & Korsinsky Notifies Iovance Biotherapeutics, Inc. (IOVA) InvestorsLead Plaintiff Deadline on July 14, 2025 - ACCESS Newswire
D. E. Shaw & Co. Inc. Reduces Holdings in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) - Defense World
Bank of America Corp DE Has $5.49 Million Position in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) - Defense World
Class Action Lawsuit Filed Against Iovance Biotherapeutics, Inc. (IOVA)Recover LossesContact Levi & Korsinsky Before July 14, 2025 - ACCESS Newswire
IOVANCE BIOTHERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK ... - Bluefield Daily Telegraph
IOVANCE BIOTHERAPEUTICS SHAREHOLDER ALERT BY FORMER - GlobeNewswire
IOVA Stock New: Contact Robbins LLP for Information About the Securities Fraud Class Action Against Iovance Biotherapeutics, Inc. and to Learn How to Be Lead Plaintiff for the Class - The Malaysian Reserve
Lost Money on Iovance Biotherapeutics, Inc. (IOVA)? Join Class Action Before July 14, 2025Contact Levi & Korsinsky - ACCESS Newswire
IOVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Iovance Biotherapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Morningstar
Iovance Biotherapeutics (IOVA) Faces Investor Lawsuit Over - GlobeNewswire
Iovance Biotherapeutics (IOVA) Faces Investor Lawsuit Over Growth Projections Following Stock Plunge – Hagens Berman - TradingView
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics - StreetInsider
Scott+Scott Attorneys at Law LLP Reminds Investors That - GlobeNewswire
Scott+Scott Attorneys at Law LLP Reminds Investors That There is a Securities Class Action Against Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) - TradingView
Iovance Biotherapeutics, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before July 14, 2025 to Discuss Your RightsIOVA - Morningstar
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Iovance Biotherapeutics, Inc.IOVA - PR Newswire
Investors Urged to Contact Levi & Korsinsky for Information Before July 14, 2025Iovance Biotherapeutics, Inc. (IOVA) - ACCESS Newswire
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Shares Sold by BNP Paribas Financial Markets - Defense World
Levi & Korsinsky Urges Iovance (IOVA) Shareholders to Act Before Lead Plaintiff Deadline July 14, 2025 - ACCESS Newswire
Iovance Biotherapeutics Inc (IOVA) 財務データ
収益
当期純利益
現金流量
EPS
1.89%
3.74%
大文字化:
|
ボリューム (24 時間):